Devon Schuyler




Experts Debate Usefulness of Vision Restoration Therapy

November 01, 2007

Vision Restoration Therapy (VRT) is an FDA-cleared device for treatment of visual field defects caused by stroke or traumatic brain injury. The therapy works by stimulating the brain to form new connections, according to NovaVision, the device's manufacturer. But critics maintain that VRT is nothing more than a pricey way to promote saccadic eye movement.

Recognition of Apathy as Marker for Dementia Growing

October 01, 2007

A recent 4-year study linked apathy to a hastened decline in persons with Alzheimer disease (AD). Another recent study found that persons with mild cognitive impairment (MCI) were more likely to convert to AD a year later if they also had apathy.

Clinical Pearls on Best Approaches to Psychogenic Movement Disorders

April 01, 2007

Five words that are guaranteed to annoy your patientwith a diagnosis of psychogenic movementdisorder (PMD) are It's all in your head.It's the worst thing you can say, said Katie Kompoliti,MD, associate professor of neurological sciencesat Rush University Medical Center in Chicago.

The Changing Epidemiology of Bacterial Meningitis

March 01, 2007

The greatest advance in reducing mortality from bacterial meningitis over the past 20 years has been the advent of widespread immunization. Vaccination has also had another effect: changing which forms of the disease are most prevalent.

Novel Rehabilitation Methods for Stroke, Cerebral Palsy, and Spinal Cord Injury

December 01, 2006

Traditional physical therapy for neurologic conditions can be boring for the patient and tiring for the physical therapist, making it difficult to put in the required number of training hours. That is why researchers are developing a new generation of physical therapy tools that use video games, robotics, and virtual reality.

Understanding and Treating Complex Regional Pain Syndrome

October 01, 2006

The Reflex Sympathetic Dystrophy Syndrome Association estimates that the CRPS affects between 200,000 and 1.2 million Americans. The underlying causes of the syndrome have yet to be defined, and no definitive diagnostic test exists even though CRPS was first described in the late 19th century by the neurologist Silas Weir Mitchell. Mitchell referred to the cluster of symptoms he noticed in some of the Civil War soldiers who were under his care as "causalgia.